Normanno, N., Esposito Abate, R., Lambiase, M., Forgione, L., Cardone, C., Iannaccone, A., Sacco, A., Rachiglio, A. M., Martinelli, E., Rizzi, D., Pisconti, S., Biglietto, M., Bordonaro, R., Troiani, T., Latiano, T. P., Giuliani, F., Leo, S., Rinaldi, A., Maiello, E., Ciardiello, F., & , (2018). rAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial. Annals of oncology, 29, 112–118. http://access.bl.uk/ark:/81055/vdc_100095504497.0x00003c